Newsbite analysis · Business
CNBC
Stocks making the biggest moves premarket
In premarket trading, Moderna and Merck experienced notable increases as their personalized cancer vaccine trials showed promising results, boosting Moderna's shares by 57%. In contrast, La-Z-Boy's shares dropped nearly 17% following poor financial performance and lowered revenue guidance. Other notable stocks include Keysight Technologies, which exceeded earnings expectations, and both Lowe's and Target experiencing mixed movements based on their guidance adjustments. Estee Lauder and Analog Devices posted gains after beating earnings forecasts.
MonitorConfidence: HighImmediate horizon
Published 19 Aug 2026, 11:55 UTC3 min read
Lead image — CNBC
Brief
NewsBite reading:Key Pre-Market Stock Moves: Moderna and Merck Surge, La-Z-Boy Plummets
TL;DR
- Moderna shares jumped 57% on positive cancer vaccine trial results.
- Merck stock increased over 6% following the same trial results.
- Keysight Technologies exceeded earnings expectations, rising 2%.
- La-Z-Boy shares dropped nearly 17% due to disappointing earnings.
- Estee Lauder's stock rose more than 7% after a strong quarterly report.
Interesting facts
- The cancer vaccine success highlights potential future collaborations.
- Lowe's guidance revision reflects broader concerns in home improvement spending.
- Target's revenue boost from tariff refunds indicates complex regulatory influences.